(Q36514103)

English

Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: A comparison between alpha blockers and different types of beta blockers with and without vasodilating effect

scientific article published on June 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: A comparison between alpha blockers and different types of beta blockers with and without vasodilating effect (English)

1 reference

10.1007/BF03029729

https://api.crossref.org/works/10.1007/BF03029729

27 October 2022

Cardiology and cardiovascular medicine

1 reference

10.1007/BF03029729

https://api.crossref.org/works/10.1007/BF03029729

27 October 2022

1 reference

10.1007/BF03029729

https://api.crossref.org/works/10.1007/BF03029729

27 October 2022

author name string

P. Lund-Johansen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678963

27 October 2022

P. Omvik

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678963

27 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1678963

27 October 2022

publication date

1 June 1991

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF03029729.pdf

Portable Document Format

1 reference

10.1007/BF03029729

https://api.crossref.org/works/10.1007/BF03029729

27 October 2022

http://link.springer.com/article/10.1007/BF03029729/fulltext.html

1 reference

10.1007/BF03029729

https://api.crossref.org/works/10.1007/BF03029729

27 October 2022

http://link.springer.com/content/pdf/10.1007/BF03029729

1 reference

10.1007/BF03029729

https://api.crossref.org/works/10.1007/BF03029729

27 October 2022

Cardiovascular Drugs and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

605-615

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise

1 reference

https://api.crossref.org/works/10.1007%2FBF03029729

21 January 2018

The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels

1 reference

https://api.crossref.org/works/10.1007%2FBF03029729

21 January 2018

Response of the systemic pulmonary circulation to labetalol at rest and during exercise

1 reference

https://api.crossref.org/works/10.1007%2FBF03029729

21 January 2018

Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1007%2FBF03029729

21 January 2018

Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients

1 reference

https://api.crossref.org/works/10.1007%2FBF03029729

21 January 2018

Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1007%2FBF03029729

21 January 2018

The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues

1 reference

https://api.crossref.org/works/10.1007%2FBF03029729

21 January 2018

Effect of beta-adrenoceptor blockade on exercise performance and metabolism.

1 reference

https://api.crossref.org/works/10.1007%2FBF03029729

21 January 2018

Mechanism of antihypertensive action of dilevalol compared with that of "cardioselective" beta-blocking agents.

1 reference

https://api.crossref.org/works/10.1007%2FBF03029729

21 January 2018

Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemodynamic aspects of essential hypertension in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fourth Sir George Pickering memorial lecture. The structure of the resistance vasculature in essential hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemodynamic effects of long-term oral labetalol

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of central haemodynamic effects of alpha-blockers and their future use in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Labetalol: a review of its pharmacology and therapeutic use in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dilevalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute Hemodynamic Effects of Labetalol in Severe Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of dilevalol on rest and supine exercise hemodynamics in mild to moderate systemic hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrinsic beta-sympathomimetic activity of dilevalol, R, R-isomer of labetalol

1 reference

https://pubmed.ncbi.nlm.nih.gov/1678963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The British journal of clinical practice

12

41

15

author name string

P Omvik

publication date

1987

1 reference

10.1007/BF03029729

https://api.crossref.org/works/10.1007/BF03029729

27 October 2022

Federation Proceedings

27

42

176

author name string

TH Baum

publication date

1983

1 reference

10.1007/BF03029729

https://api.crossref.org/works/10.1007/BF03029729

27 October 2022

Identifiers

10.1007/BF03029729

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36514103&oldid=1759067603"